用药依从性设备市场 - 2018-2028年全球行业规模、份额、趋势、机会和预测F 按类型、按药物、按地区和竞争情况分类

在预测期内，全球用药依从性设备市场预计将出现令人瞩目的增长。这主要得益于越来越多的计划和活动旨在教育人们坚持用药的重要性。此外，老龄化人口的不断增加、医疗保健支出的不断增长以及药品使用量的不断上升，预计也将在预测期内为市场创造巨大的增长机会。同样，心血管疾病发病率的增长也是多年来推动市场增长的主要因素。此外，心脏病患者不遵医嘱用药的高发率也导致了预测期内对遵医设备的需求。广泛的研发（R&D）支出和不断扩大的医疗成本也会促进市场的增长。根据美国疾病控制和预防中心（CDC）的数据，2019 年美国 10 个主要死因中有 7 个是慢性病。在各种慢性病中，心脏病和癌症共占 2019 年美国死亡总人数的近 46%。

心血管疾病发病率不断上升

慢性疾病通常需要使用大剂量药物进行长期治疗干预，任何中断服药的行为都可能造成致命后果，因此需要严格遵守用药规定，这将在预测期内进一步推动市场增长。心血管疾病是全球主要慢性疾病之一。冠心病综合征、脑血管疾病、风湿性心脏病和其他疾病是最常见的心血管疾病。据世界卫生组织（WHO）统计，全球每年死于心血管疾病的人数占总死亡人数的 32%，即 1790 万人。此外，由于心脏结构和功能的逐渐退化，越来越多的老年人群很容易出现心脏缺陷，这在很大程度上加重了心血管疾病的负担；因此，在预测期内，先进的遵医嘱用药设备的采用率会越来越高。由于遗传因素和环境因素，氧化应激性心脏病正在迅速增加。慢性疾病的改善需要临床干预，而临床干预则是通过提高以患者为中心的用药依从性计划的参与度来实现的，这推动了全球用药依从性设备市场的扩大。

对高级用药依从性的需求不断增长

在预测期内，对高级用药依从性系统日益增长的需求将推动全球用药依从性设备市场的增长。在全球范围内，医疗保健生态系统因先进诊断和治疗市场参与者的存在而变得支离破碎。医疗保健专业人员和患者之间的协调不断加强，提高了医疗保健的质量和成本，因为这导致了医疗保健信息（如病史、患者人口统计、账单、诊断和管理数据）的碎片化，而这反过来又有望在未来几年内促进市场的增长。

坚持用药的意识不断增强

由于发起了拯救病人的计划，人们对坚持用药的认识不断提高，这是推动坚持用药设备市场在预测期内增长的一个主要因素。坚持用药计划有助于提高患者的依从性。用药依从性设备还能帮助药剂师识别未按时服药的患者。此外，各种政府和非政府组织也在赞助各种活动和会议，对患者和护理人员进行用药依从性教育，从而推动了全球用药依从性设备市场的多年增长。2021 年 8 月，西奈山医疗系统开始使用一款首创的移动应用程序，以加快和加强对心脏病发作患者的护理。该应用程序由西奈山的介入心脏病专家、急诊科医生和护理团队共同开发，可改善医生、护士和临床指挥中心之间的沟通，使患者能得到更快速的护理，从而改善预后。

最新进展

• 2018 年 11 月，AdhereTech 公司宣布获得 Argentum 集团的投资。该公司表示，有了这笔新融资，它将增加药房和制药合作伙伴关系，并扩展到更多的医疗保健垂直领域。
• 2021 年 9 月：Curant Health 与美国人保公司（Humana Inc.这项新颖的试点计划旨在改善患者的用药依从性，帮助他们过上更健康的生活，并最终帮助降低医疗成本。

可用的定制服务

TechSci Research 可根据给定的市场数据，按照公司的具体需求提供定制服务。本报告提供以下定制选项：

公司信息

• 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 覆盖市场
  • 研究年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基准方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概述
• 主要市场细分概述
• 主要市场参与者概述
• 主要地区/国家概述
• 市场驱动因素、挑战和趋势概述

第4章：客户之声

第5章：全球用药依从性设备市场展望

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按类型（以硬件为中心和以软件为中心）
  • 按药物（心血管、中枢神经系统、糖尿病、肿瘤、胃肠道、肌肉骨骼、其他）
  • 按地区
  • 按公司（2022 年）
• 产品地图

第 6 章 : 北美用药依从性设备市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按类型（以硬件为中心和以软件为中心）
  • 按药物（心血管、中枢神经系统、糖尿病、肿瘤、胃肠道、肌肉骨骼、其他）
  • 按国家
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲用药依从性设备市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按类型（以硬件为中心和以软件为中心）
  • 按药物（心血管、中枢神经系统、糖尿病、肿瘤、胃肠道、肌肉骨骼、其他）
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章 : 亚太地区用药依从性设备市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按类型（以硬件为中心和以软件为中心）
  • 按药物（心血管、中枢神经系统、糖尿病、肿瘤、胃肠道、肌肉骨骼、其他）
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章 : 南美洲用药依从性设备市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按类型（以硬件为中心和以软件为中心）
  • 按药物（心血管、中枢神经系统、糖尿病、肿瘤、胃肠道、肌肉骨骼、其他）
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章 : 中东和非洲用药依从性设备市场前景

• 市场规模与预测
  • 按价值
• 市场份额与预测
  • 按类型（以硬件为中心和以软件为中心）
  • 按药物（心血管、中枢神经系统、糖尿病、肿瘤、胃肠道、肌肉骨骼、其他）
  • 按国家
• 中东和非洲：国家分析
  • 南非用药依从性设备
  • 沙特阿拉伯用药依从性设备
  • 阿联酋用药依从性设备

第 11 章 ：市场动态

• 驱动因素
• 挑战

第 12 章 ：市场趋势与发展

第 13 章 ：全球用药依从性设备市场：SWOT分析

第14章：波特五力分析法

• 行业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第 15 章 ：竞争格局

• 业务概述
• 产品供应
• 近期发展
• 财务状况（报告）
• 主要人员
• SWOT 分析
  • CareFusion.
  • Proteus Digital Health.
  • DrFirst.com,Inc.
  • AdhereTech Inc.
  • MedMinder.
  • Caredose.
  • Fruitech Ltd.
  • PHC Holdings Corporation.
  • MedAdvisor International Pty Ltd.
  • McKesson Corporation.

第 16 章 ：战略建议

Global Medication Adherence Devices market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing programs and initiatives organized to educate people about the significance of medical adherence. Also, the growing aging population, increasing development of healthcare expenditure, and rising usage of pharmaceuticals are expected to create significant growth opportunities for the market during the forecast period. Similarly, the growing prevalence of cardiovascular diseases is the major factor fuelling the growth of the market over the years. Additionally, the high frequency non-adherence to medication among cardiac patients has resulted in demand for medical adherence devices in the forecast period. The extensive research and development (R&D) expenditures, and expanding healthcare costs can boost the growth of the market. According to the US Centers for Disease Control and Prevention (CDC), 7 out of the 10 major causes of death in 2019 in the US were chronic illnesses. Among the various chronic diseases, heart diseases and cancer together accounted for nearly 46% of all deaths in the US in 2019.

Growing Prevalence of Cardiovascular Diseases

Most often, chronic diseases require a long therapeutic intervention by using high-dose drugs and any interruption in the medication intake can create fatal consequences which need strict medication adherence and will further boost the growth of the market during the forecast period. Cardiovascular diseases are one of the major chronic diseases across the world. Coronary heart syndrome, cerebrovascular diseases, rheumatic heart diseases, and other illnesses are among the most commonly observed cardiovascular diseases. According to the World Health Organization (WHO), 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year. Furthermore, the increasing geriatric population is susceptible to heart defects due to progressive deterioration in the structure and function of the heart, which largely contributes to the high burden of CVDs; thereby triggering the increased adoption of advanced medication adherence devices during the forecast period. Due to genetic factors, environmental factors, the oxidative stress heart diseases are increasing rapidly. The improvement of chronic diseases necessitates clinical intervention, which is accomplished by increasing the participation of patient-centric medication adherence programs, fuelling the expansion of the global medication adherence devices market.

Growing Demand for Advanced Medication Adherence

The growing demand for advanced medication adherence systems is driving the global medication adherence devices market growth in the forecast period. The healthcare ecosystem is fragmented across the globe by the presence of market players for the advanced diagnosis and treatment. The growing coordination among healthcare professionals and patients has enhanced the quality of care and its cost, as it leads to the fragmentation of healthcare information such as medical history, patient demographics, billing, diagnosis and administrative data, and this in turn is expected to boost the growth of the market over the years.

Growing Awareness about Medication Adherence

The growing awareness of medication adherence, on account of the patient-saving programs being initiated, is a major factor fuelling the growth of the medication adherence devices market in the forecast period. Medication adherence programs help in improving patient compliance. Medical adherence devices also aid pharmacists in identifying patients missing out on the timely intake of medicines. Besides, various government and non-government organizations are sponsoring events and conferences to educate patients and caregivers about medication adherence thereby driving the global medication adherence devices market growth over the years. In August 2021, Mount Sinai Health System started using a first-of-its-kind mobile application to expedite and enhance care for patients with heart attacks. The app, developed by Mount Sinai's interventional cardiologists, emergency department physicians, and the nursing team, improves communication among doctors, nurses, and the clinical command center so that patients can get more rapid care to improve outcomes.

Market Segmentation

Global Medication Adherence Devices Market can be segmented by type, medication, region and competitional landscape. Based on the type, the market can be divided into hardware centric and software centric. Based on medication, the market can be segmented into cardiovascular, central nervous system, diabetes, oncology, gastrointestinal, musculoskeletal, and others. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominates the global medication adherence devices market on account of the increasing prevalence of cardiovascular diseases in the country.

Market Players

CareFusion., Proteus Digital Health., DrFirst.com, Inc., AdhereTech Inc., MedMinder., Caredose. Fruitech Ltd., PHC Holdings Corporation, MedAdvisor International Pty Ltd., McKesson Corporation. are some of the leading players operating in the Global Medication Adherence Devices Market.

Recent Developments

• In November 2018, AdhereTech Inc., announced receiving investment from Argentum Group. The company stated that with this new financing it would be increasing its pharmacy and pharmaceutical partnerships and expand into more healthcare verticals.
• September 2021: Curant Health and Humana Inc. teamed up to help in achieving better health outcomes for Humana members suffering from Chronic Obstructive Pulmonary Disease (COPD) and Chronic Heart Failure (CHF). The novel pilot program, aimed at refining medication adherence to help patients lead healthier lives and eventually help lessen health care costs, offers inclusive support for members suffering from complex health conditions and prescription medication needs.

Report Scope

In this report, Global Medication Adherence Devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medication Adherence Devices Market, By Type:

• Hardware Centric
• Software Centric

Medication Adherence Devices Market, By Medication:

• Cardiovascular
• Central Nervous System
• Diabetes
• Oncology
• Gastrointestinal
• Musculoskeletal
• Others

Medication Adherence Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medication Adherence Devices Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medication Adherence Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Hardware Centric v/s Software Centric)
  • 5.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Product Map

6. North America Medication Adherence Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Hardware Centric v/s Software Centric)
  • 6.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Medication Adherence Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Medication
  • 6.3.2. Canada Medication Adherence Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Medication
  • 6.3.3. Mexico Medication Adherence Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Medication

7. Europe Medication Adherence Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Hardware Centric v/s Software Centric)
  • 7.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Medication Adherence Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Medication
  • 7.3.2. Germany Medication Adherence Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Medication
  • 7.3.3. United Kingdom Medication Adherence Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Medication
  • 7.3.4. Italy Medication Adherence Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Medication
  • 7.3.5. Spain Medication Adherence Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Medication

8. Asia-Pacific Medication Adherence Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Hardware Centric v/s Software Centric)
  • 8.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Medication Adherence Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Medication
  • 8.3.2. India Medication Adherence Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Medication
  • 8.3.3. Japan Medication Adherence Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Medication
  • 8.3.4. South Korea Medication Adherence Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Medication
  • 8.3.5. Australia Medication Adherence Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Medication

9. South America Medication Adherence Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Hardware Centric v/s Software Centric)
  • 9.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Medication Adherence Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Medication
  • 9.3.2. Argentina Medication Adherence Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Medication
  • 9.3.3. Colombia Medication Adherence Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Medication

10. Middle East and Africa Medication Adherence Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Hardware Centric v/s Software Centric)
  • 10.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Medication Adherence Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Medication
  • 10.3.2. Saudi Arabia Medication Adherence Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Medication
  • 10.3.3. UAE Medication Adherence Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Medication

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. Global Medication Adherence Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 CareFusion.
  • 15.6.2 Proteus Digital Health.
  • 15.6.3 DrFirst.com,Inc.
  • 15.6.4 AdhereTech Inc.
  • 15.6.5 MedMinder.
  • 15.6.6 Caredose.
  • 15.6.7 Fruitech Ltd.
  • 15.6.8 PHC Holdings Corporation.
  • 15.6.9 MedAdvisor International Pty Ltd.
  • 15.6.10 McKesson Corporation.

16. Strategic Recommendations